Lhrh Agonists Versus Antagonists In Advanced Prostate Cancer

LHRH Agonists Versus Antagonists in Advanced Prostate Cancer

ADT for Prostate Cancer: Agonists vs Antagonists

Grand Rounds in Urology

Use of LHRH Agonists Versus Antagonists in Prostate Cancer

Dr. Olsson on Differences Between LHRH Agonists and Antagonists in Prostate Cancer

Dr. Berry on LHRH Antagonists Versus Agonists for Prostate Cancer

ADT: Agonists Versus Antagonists

Dr. Berry on the Differences Between LHRH Antagonists and Agonists

Dr. Cone on Evaluating the Relative Risk of GnRH Agonists Versus Antagonists in Prostate Cancer

Dr. Sandler Explains Traditional LHRH Agonists Versus Newer Drugs

New Concepts in ADT

Grand Rounds in Urology

Dr. Shore on Degarelix Versus LHRH Agonists in Prostate Cancer

ADT With GnRH Antagonists in Prostate Cancer

Dr. Crawford on LHRH Agonist and GNRH Antagonist

Dr. David Crawford Compares Degarelix and LHRH Agonists

Decisions on Choosing LHRH Agonists for Treating Prostate Cancer

Disease Flare with LHRH Agonists is a Myth

Grand Rounds in Urology

Timing of ADT and Chemotherapy

Grand Rounds in Urology

ADT as Foundational Therapy: Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

Grand Rounds in Urology

Dr. Cone on Research Investigating Cardiac Toxicity of GnRH Agonists/Antagonists in Prostate Cancer

Dr Mahendra Pal | Unleashing the Controversy LHRH Agonists & LHRH Antagonists

CRSF - Cancer Research and Statistic Foundation